Hepatic Insufficiency - 27 Studies Found
| Completed |
: Pharmacokinetics and Pharmacodynamics of BI 1356 in Subjects With Different Degrees of Liver Impairment as Compared to Healthy Subjects : Hepatic Insufficiency : 2014-07-04 : Drug: BI 1356 |
| Completed |
: Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Dabigatran Etexilate in Patients With Moderate Hepatic Impairment Compared to Subjects With Normal Hepatic Function : Hepatic Insufficiency : 2014-06-20 : Drug: Dabigatran etexilate |
| Completed |
: Extracorporeal Photopheresis After Liver Transplant : Hepatic Insufficiency : 2013-09-19 : Procedure: Extracorporeal photopheresis Extracorporeal photopheresis with Methoxsalen(UVADEX)and immunos |
| Completed |
: A Study of Evacetrapib (LY2484595) in Participants With Hepatic (Liver) Impairment : Hepatic Insufficiency : 2013-04-17 : Drug: Evacetrapib Other Name: LY2484595 |
| Completed |
: A Study of LY2140023 in Hepatic Impaired Participants : Hepatic Insufficiency : 2011-11-16 : Drug: LY2140023 Administered orally |
| Completed |
: Pharmacokinetics of 9-cis-retinoic Acid (Alitretinoin, Toctino®) in Patients With Hepatic Disease : Hepatic Insufficiency : 2010-12-15 : Drug: Alitretinoin 30 mg capsule of 9-cis-retinoic-acid (9-cis-RA)(Alitretinoin, Toctino®) |
| Completed |
: Hepatic Impaired Subjects Compared to Healthy Subjects Receiving Multi-dose BMS-650032 : Hepatic Insufficiency : 2009-11-24 : Drug: BMS-650032 Capsules, Oral, 200 mg, BID, 7 Days |
| Completed |
: Single-Dose Pharmacokinetics of BMS-790052 in Participants With Hepatic Impairment : Hepatic Insufficiency : 2009-03-06 : Drug: BMS-790052 Capsules, Oral, 30 mg, single dose, one day |
| Completed |
: Study Evaluating The PK And Safety Of Neratinib In Healthy Subjects And Subjects With Chronic Liver Disease : Hepatic Insufficiency : 2008-10-28 : Drug: Neratinib (HKI-272) Neratinib 40-mg oral tablets. SINGLE DOSE of 120-mg (3 x 40-mg tablets) |
| Completed |
: Evaluation Of Hepatic Impairment On AG-013736 Pharmacokinetics : Hepatic Insufficiency : 2008-06-04 : Drug: AG-013736 Single oral 5-mg dose of AG-013736, administered as a film-coated, immediate-release tab |